Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Clinical trial NCT07498647 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07498647
Sponsor: BioRay Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gout and Hyperuricemia

Start date: 2026-04-01
Primary completion: 2026-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.